KRSA Korsana Biosciences, Inc. - Common Stock
NASDAQ · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Jul 28, 2023KRSA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
KRSA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
| Ex-date | Split | Type |
|---|---|---|
| Sept. 9, 2026 | 1-for-7 | Reverse |
| May 16, 2023 | 1-for-20 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Not enough fundamentals data to compute this ratio group yet.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
Not enough fundamentals data to compute this ratio group yet.
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
We don't have SEC filings for this ticker yet.
Per Share
| Metric | Trend | Q4 2023 |
|---|---|---|
| EPS (TTM) | $-18.85 |
Valuation (TTM)
| Metric | Trend | Q4 2023 |
|---|---|---|
| Revenue TTM | $-720.0K | |
| Net Income TTM | $-29M |
Most recent period on the left · null values shown as ·
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Bong Y. Koh, Nimish Shah, VHCP Co-Investment Holdings III, LLC, VHCP Management EG, LLC, VHCP Management III, LLC, VHCP Management XP, LLC, Venrock Healthcare Capital Partners EG, L.P., Venrock Healthcare Capital Partners III, L.P., Venrock Healthcare Capital Partners XP, L.P. | Sept. 15, 2026 | 9.90% | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
KRSA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
12-Month Price Target
3 analysts · 2026-09-28Mean target $35.33 +15.9%
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.